These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6184569)

  • 41. Effect of nifedipine and verapamil on alpha-receptor-activation in patients with essential hypertension.
    Fritschka E; Distler A; Lenz T; Kribben A; Schudrowitsch L; Philipp T
    J Hypertens Suppl; 1984 Dec; 2(3):S535-8. PubMed ID: 6100753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The hemodynamic reactions of hypertension patients taking the calcium antagonists finoptin and korinfar].
    Goloshchapov OA; Goldabin VI; Geller AL; Mashin AA
    Ter Arkh; 1990; 62(10):149-52. PubMed ID: 2084881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A comparison of the effects of verapamil and nifedipine on the quality of life].
    Palmer A; Fletcher A; Hamilton G; Muriss S; Bulpitt C
    Wien Med Wochenschr; 1991; 141(18-19):424-8. PubMed ID: 1776257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nifedipine or verapamil as sole treatment of hypertension. An intraarterial study.
    Gould BA; Hornung RS; Mann S; Subramanian VB; Raftery EB
    Hypertension; 1983; 5(4 Pt 2):II91-6. PubMed ID: 6862589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Foridone and other calcium antagonists in the treatment of essential hypertension.
    Andreeva TN
    Cor Vasa; 1990; 32(1):45-55. PubMed ID: 2160361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of a calcium antagonist, verapamil, on mild-moderate essential arterial hypertension].
    Hergueta García de Guadiana G; Paumard Fraguas A
    An Med Interna; 1989 Jan; 6(1):15-8. PubMed ID: 2491026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Calcium antagonists in the treatment of nephrogenic hypertension].
    Tareeva IE; Kutyrina IM; Galstian GM; Rogov VA
    Klin Med (Mosk); 1990 Aug; 68(8):52-6. PubMed ID: 2084371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical use of calcium channel blockers as ventricular unloading agents.
    Guazzi MD; Cipolla C; Sganzerla P; Agostoni PG; Fabbiocchi F; Pepi M
    Eur Heart J; 1983 Jan; 4 Suppl A():181-7. PubMed ID: 6220895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The calcium antagonist isradipine in the therapy of hypertension. A double-blind crossover comparison with nifedipine.
    Welzel D; Burger KJ
    Drugs; 1990; 40 Suppl 2():60-4. PubMed ID: 2150644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment procedures in the vasoconstrictive form of hypertension using calcium antagonists in relation to their effect on kidney function].
    Tikhonov VP; Zenchenko DI
    Ter Arkh; 1989; 61(7):108-12. PubMed ID: 2588128
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of amlodipine and verapamil in the treatment of mild to moderate hypertension.
    Lorimer AR; Smedsrud T; Walker P; Tyler HM
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S89-93. PubMed ID: 2467138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calcium antagonists and beta blockers in the control of mild to moderate systemic hypertension, with particular reference to verapamil and propranolol.
    Singh BN; Rebanal P; Piontek M; Nademanee K
    Am J Cardiol; 1986 Feb; 57(7):99D-105D. PubMed ID: 2869676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Randomized double-blind study of delayed-action verapamil as a single dose versus 2 doses daily in patients with moderate hypertension].
    Chapelon-Abric C; Wajman A; Villarroya A; Godeau P
    Ann Cardiol Angeiol (Paris); 1991 Apr; 40(4):215-8. PubMed ID: 2053765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Verapamil and nitrendipine in beta blocker-resistant hypertensive patients].
    Edmonds D; Förster E; Wehling M; Siegenthaler W; Vetter W
    Schweiz Rundsch Med Prax; 1985 May; 74(19):510-3. PubMed ID: 3160098
    [No Abstract]   [Full Text] [Related]  

  • 55. Calcium antagonists in the treatment of hypertension. An overview.
    Ram CV; Featherston WE
    Chest; 1988 Jun; 93(6):1251-3. PubMed ID: 3286142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term efficacy of calcium antagonists in resistant hypertension.
    Robinson BF; Bayley S; Dobbs RJ
    Hypertension; 1983; 5(4 Pt 2):II122-4. PubMed ID: 6345371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of calcium-entry antagonists in hypertension.
    Krebs R; Graefe KH; Ziegler R
    Clin Exp Hypertens A; 1982; 4(1-2):271-84. PubMed ID: 7074989
    [No Abstract]   [Full Text] [Related]  

  • 58. [Dynamic behavior of arterial pressure during exertion. Effects of treatment with 2 different calcium blockers: nifedipine and verapamil].
    González Juanatey JR; Pose Reino A; Amaro Cendón A; Gil de la Peña M
    Med Clin (Barc); 1988 Apr; 90(16):651-5. PubMed ID: 3294533
    [No Abstract]   [Full Text] [Related]  

  • 59. [Calcium antagonists: hemodynamic effects in hypertensive patients].
    Arata L; Di Renzi L; Giannico S; Fedele F; Pastore LR; Penco M; Agati L
    Boll Soc Ital Cardiol; 1979; 24(8):833-41. PubMed ID: 551807
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of hypertensive crises with calcium antagonists].
    Nicita-Mauro V; Barbera N; Savica V; Frisina N; Ceruso D
    Boll Soc Ital Cardiol; 1978; 23(9):1469-76. PubMed ID: 553621
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.